Akeso Launches Innovative Trispecific Antibody AK150 to Tackle Immunotherapy Resistance in Cancer Treatment Akeso, Inc. has unveiled its groundbreaking trispecific antibody, AK150, which has received IND clearance for clinical trials targeting advanced tumors. This innovation aims to enhance immunotherapy effectiveness.

Akeso Launches Innovative Trispecific Antibody AK150 to Tackle Immunotherapy Resistance in Cancer Treatment #China #Hong_Kong #Immunotherapy #Akeso #AK150

Flyer: Donnerstag, 18. Juli 2024, 19.30 Uhr Podiumsdiskussion: Gott queer gedacht? Gottesbilder im Dialog

Im Rahmen des 150jährigen Gemeindejubiläums #AK150 findet am 18. Juli eine Podiumsdiskussion "Gott queer gedacht" statt. #altkatholisch #CSD #ColognePride